| URL | Name: | [(2~{S})-2-azanyl-4-methyl-pentyl]carbamic acid | Formula: | C7 H16 N2 O2 | SMILES: | CC(C)C[CH](N)CNC(O)=O | InChi: | InChI=1S/C7H16N2O2/c1-5(2)3-6(8)4-9-7(10)11/h5-6,9H,3-4,8H2,1-2H3,(H,10,11)/t6-/m0/s1 | Definition date: | 2018-08-22 | Last modified: | 2024-09-27 | Release date: | 2021-02-17 | Identifier: | [(2~{S})-2-azanyl-4-methyl-pentyl]carbamic acid |
|
| TLK | Name: | 3-methoxy-4-(2-phenylimidazol-1-yl)benzaldehyde | Formula: | C17 H14 N2 O2 | SMILES: | COc1cc(C=O)ccc1n2ccnc2c3ccccc3 | InChi: | InChI=1S/C17H14N2O2/c1-21-16-11-13(12-20)7-8-15(16)19-10-9-18-17(19)14-5-3-2-4-6-14/h2-12H,1H3 | Definition date: | 2021-01-11 | Last modified: | 2024-09-27 | Release date: | 2021-06-16 | Identifier: | 3-methoxy-4-(2-phenylimidazol-1-yl)benzaldehyde |
|
| RJR | Name: | (1~{S},2~{R},3~{R},4~{S},5~{S})-4-[[4-[3-(1-adamantylmethoxy)propyl]-1,2,3-triazol-1-yl]methyl]cyclohexane-1,2,3,5-tetrol | Formula: | C23 H37 N3 O5 | SMILES: | O[CH]1C[CH](O)[CH](Cn2cc(CCCOCC34CC5CC(CC(C5)C3)C4)nn2)[CH](O)[CH]1O | InChi: | InChI=1S/C23H37N3O5/c27-19-7-20(28)22(30)21(29)18(19)12-26-11-17(24-25-26)2-1-3-31-13-23-8-14-4-15(9-23)6-16(5-14)10-23/h11,14-16,18-22,27-30H,1-10,12-13H2/t14-,15+,16-,18-,19-,20-,21+,22+,23-/m0/s1 | Definition date: | 2018-12-11 | Last modified: | 2024-09-27 | Release date: | 2019-03-27 | Identifier: | (1~{S},2~{R},3~{R},4~{S},5~{S})-4-[[4-[3-(1-adamantylmethoxy)propyl]-1,2,3-triazol-1-yl]methyl]cyclohexane-1,2,3,5-tetrol |
|
| I5M | Name: | 5'-deoxy-5'-({(2S)-2-({2-[(N-{(2R)-4-[(dioxo-lambda~5~-phosphanyl)oxy]-2-hydroxy-3,3-dimethylbutanoyl}-beta-alanyl)amino]ethyl}sulfanyl)-2-[(2S)-pyrrolidin-2-yl]ethanesulfonyl}amino)adenosine | Formula: | C27 H44 N9 O11 P S2 | SMILES: | O=P(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSC(CS(=O)(=O)NCC1OC(n2cnc3c(N)ncnc32)C(O)C1O)C1CCCN1 | InChi: | InChI=1S/C27H44N9O11PS2/c1-27(2,12-46-48(42)43)22(40)25(41)31-7-5-18(37)30-8-9-49-17(15-4-3-6-29-15)11-50(44,45)35-10-16-20(38)21(39)26(47-16)36-14-34-19-23(28)32-13-33-24(19)36/h13-17,20-22,26,29,35,38-40H,3-12H2,1-2H3,(H,30,37)(H,31,41)(H2,28,32,33)/t15-,16+,17+,20+,21+,22-,26+/m0/s1 | Definition date: | 2022-01-13 | Last modified: | 2024-09-27 | Release date: | 2022-07-20 | Identifier: | 5'-deoxy-5'-({(2S)-2-({2-[(N-{(2R)-4-[(dioxo-lambda~5~-phosphanyl)oxy]-2-hydroxy-3,3-dimethylbutanoyl}-beta-alanyl)amino]ethyl}sulfanyl)-2-[(2S)-pyrrolidin-2-yl]ethanesulfonyl}amino)adenosine |
|
| SRU | Name: | 1-[(5S)-5-(3,4-dimethoxyphenyl)-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl]ethan-1-one | Formula: | C19 H20 N2 O3 | SMILES: | O=C(C)N1N=C(CC1c1ccc(OC)c(OC)c1)c1ccccc1 | InChi: | InChI=1S/C19H20N2O3/c1-13(22)21-17(12-16(20-21)14-7-5-4-6-8-14)15-9-10-18(23-2)19(11-15)24-3/h4-11,17H,12H2,1-3H3/t17-/m0/s1 | Definition date: | 2022-07-08 | Last modified: | 2024-09-27 | Release date: | 2023-05-17 | Identifier: | 1-[(5S)-5-(3,4-dimethoxyphenyl)-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl]ethan-1-one |
|
| W28 | Name: | N-[(2S)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-1H-indole-2-carboxamide | Formula: | C22 H30 N4 O4 | SMILES: | CC(C)CC(NC(=O)c1cc2ccccc2[NH]1)C(=O)NC(CC1CCNC1=O)CO | InChi: | InChI=1S/C22H30N4O4/c1-13(2)9-18(21(29)24-16(12-27)10-15-7-8-23-20(15)28)26-22(30)19-11-14-5-3-4-6-17(14)25-19/h3-6,11,13,15-16,18,25,27H,7-10,12H2,1-2H3,(H,23,28)(H,24,29)(H,26,30)/t15-,16-,18-/m0/s1 | Definition date: | 2023-09-21 | Last modified: | 2024-09-27 | Release date: | 2024-02-07 | Identifier: | N-[(2S)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-1H-indole-2-carboxamide |
|
| WZJ | Name: | N-methyl-L-alloisoleucine | Formula: | C7 H15 N O2 | SMILES: | N(C)C(C(=O)O)C(C)CC | InChi: | InChI=1S/C7H15NO2/c1-4-5(2)6(8-3)7(9)10/h5-6,8H,4H2,1-3H3,(H,9,10)/t5-,6+/m1/s1 | Definition date: | 2020-11-19 | Last modified: | 2024-09-27 | Release date: | 2020-12-30 | Identifier: | N-methyl-L-alloisoleucine |
|
| HBE | Name: | (2~{R},3~{S},4~{S},5~{R},6~{S})-5-(hydroxymethyl)-7-oxabicyclo[4.1.0]heptane-2,3,4-triol | Formula: | C7 H12 O5 | SMILES: | OC[CH]1[CH](O)[CH](O)[CH](O)[CH]2O[CH]12 | InChi: | InChI=1S/C7H12O5/c8-1-2-3(9)4(10)5(11)7-6(2)12-7/h2-11H,1H2/t2-,3+,4+,5-,6+,7-/m1/s1 | Definition date: | 2018-12-03 | Last modified: | 2024-09-27 | Release date: | 2019-10-09 | Identifier: | (2~{R},3~{S},4~{S},5~{R},6~{S})-5-(hydroxymethyl)-7-oxabicyclo[4.1.0]heptane-2,3,4-triol |
|
| YQV | Name: | methyl {(1S,2R)-2-[(1S)-2-(azetidin-1-yl)-1-(3-fluorophenyl)-1-{1-[(3-methoxy-1-{4-[(1S,4S)-5-propanoyl-2,5-diazabicyclo[2.2.1]heptane-2-sulfonyl]phenyl}azetidin-3-yl)methyl]piperidin-4-yl}ethyl]cyclopentyl}carbamate | Formula: | C42 H59 F N6 O6 S | SMILES: | O=S(=O)(c1ccc(cc1)N1CC(CN2CCC(CC2)C(CN2CCC2)(c2cccc(F)c2)C2CCCC2NC(=O)OC)(OC)C1)N1CC2CC1CN2C(=O)CC | InChi: | InChI=1S/C42H59FN6O6S/c1-4-39(50)48-24-35-23-34(48)25-49(35)56(52,53)36-14-12-33(13-15-36)47-27-41(28-47,55-3)26-46-20-16-30(17-21-46)42(29-45-18-7-19-45,31-8-5-9-32(43)22-31)37-10-6-11-38(37)44-40(51)54-2/h5,8-9,12-15,22,30,34-35,37-38H,4,6-7,10-11,16-21,23-29H2,1-3H3,(H,44,51)/t34-,35-,37-,38-,42-/m0/s1 | Definition date: | 2021-03-24 | Last modified: | 2024-09-27 | Release date: | 2021-08-11 | Identifier: | methyl {(1S,2R)-2-[(1S)-2-(azetidin-1-yl)-1-(3-fluorophenyl)-1-{1-[(3-methoxy-1-{4-[(1S,4S)-5-propanoyl-2,5-diazabicyclo[2.2.1]heptane-2-sulfonyl]phenyl}azetidin-3-yl)methyl]piperidin-4-yl}ethyl]cyclopentyl}carbamate |
|
| V7P | Name: | (2S)-2-amino-3-(6-fluoroquinolin-4-yl)propanal | Formula: | C12 H11 F N2 O2 | SMILES: | c2(F)ccc1c(c(ccn1)CC(C=O)N)c2 | InChi: | InChI=1S/C12H11FN2O2/c13-8-1-2-11-9(6-8)7(3-4-15-11)5-10(14)12(16)17/h1-4,6,10H,5,14H2,(H,16,17)/t10-/m0/s1 | Definition date: | 2020-07-13 | Last modified: | 2024-09-27 | Release date: | 2020-11-18 | Identifier: | (2S)-2-amino-3-(6-fluoroquinolin-4-yl)propanal |
|
| TZW | Name: | 4-nitro-3-(4-oxidanylpiperidin-1-yl)benzaldehyde | Formula: | C12 H14 N2 O4 | SMILES: | OC1CCN(CC1)c2cc(C=O)ccc2[N](=O)=O | InChi: | InChI=1S/C12H14N2O4/c15-8-9-1-2-11(14(17)18)12(7-9)13-5-3-10(16)4-6-13/h1-2,7-8,10,16H,3-6H2 | Definition date: | 2021-01-15 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 4-nitro-3-(4-oxidanylpiperidin-1-yl)benzaldehyde |
|
| QDD | Name: | 2-(8-azanyl-2-methanoyl-quinolin-4-yl)ethanoic acid | Formula: | C12 H10 N2 O4 | SMILES: | Nc1cccc2c(CC(O)=O)cc(nc12)C(O)=O | InChi: | InChI=1S/C12H10N2O4/c13-8-3-1-2-7-6(5-10(15)16)4-9(12(17)18)14-11(7)8/h1-4H,5,13H2,(H,15,16)(H,17,18) | Definition date: | 2018-10-24 | Last modified: | 2024-09-27 | Release date: | 2019-09-18 | Identifier: | 8-azanyl-4-(2-hydroxy-2-oxoethyl)quinoline-2-carboxylic acid |
|
| XDD | Name: | N-[(1S,2S)-2-aminocyclopentyl]-N-[(6-amino-9H-purin-9-yl)acetyl]glycine | Formula: | C14 H19 N7 O3 | SMILES: | C(n1cnc2c1ncnc2N)C(=O)N(CC(O)=O)C3CCCC3N | InChi: | InChI=1S/C14H19N7O3/c15-8-2-1-3-9(8)21(5-11(23)24)10(22)4-20-7-19-12-13(16)17-6-18-14(12)20/h6-9H,1-5,15H2,(H,23,24)(H2,16,17,18)/t8-,9-/m0/s1 | Definition date: | 2020-12-11 | Last modified: | 2024-09-27 | Release date: | 2020-12-23 | Identifier: | N-[(1S,2S)-2-aminocyclopentyl]-N-[(6-amino-9H-purin-9-yl)acetyl]glycine |
|
| SDJ | Name: | (2S)-3-(1H-imidazol-5-yl)-2-({[(3S,4aR,8aS)-2-(N-phenyl-beta-alanyl)decahydroisoquinolin-3-yl]methyl}amino)propanal | Formula: | C25 H35 N5 O2 | SMILES: | O=C(N3C(CNC(C=O)Cc1ncnc1)CC2CCCCC2C3)CCNc4ccccc4 | InChi: | InChI=1S/C25H35N5O2/c31-17-23(13-22-14-26-18-29-22)28-15-24-12-19-6-4-5-7-20(19)16-30(24)25(32)10-11-27-21-8-2-1-3-9-21/h1-3,8-9,14,17-20,23-24,27-28H,4-7,10-13,15-16H2,(H,26,29)/t19-,20-,23+,24+/m1/s1 | Definition date: | 2015-07-03 | Last modified: | 2024-09-27 | Release date: | 2016-06-22 | Identifier: | (2S)-3-(1H-imidazol-5-yl)-2-({[(3S,4aR,8aS)-2-(N-phenyl-beta-alanyl)decahydroisoquinolin-3-yl]methyl}amino)propanal |
|
| T6V | Name: | N-[(3S)-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-thiophen-3-yl]-N-phenylacetamide | Formula: | C12 H13 N O3 S | SMILES: | c1cc(ccc1)N(C(C)=O)C2C=CS(C2)(=O)=O | InChi: | InChI=1S/C12H13NO3S/c1-10(14)13(11-5-3-2-4-6-11)12-7-8-17(15,16)9-12/h2-8,12H,9H2,1H3/t12-/m0/s1 | Definition date: | 2020-03-16 | Last modified: | 2024-09-27 | Release date: | 2020-03-25 | Identifier: | N-[(3S)-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-thiophen-3-yl]-N-phenylacetamide |
|
| W2C | Name: | (2S,4S)-N-[(2S)-1-azanylidene-3-[4-(4-cyanophenyl)phenyl]propan-2-yl]-4-oxidanyl-piperidine-2-carboxamide | Formula: | C22 H24 N4 O2 | SMILES: | O=C(NC(C=[N@H])Cc2ccc(c1ccc(C#N)cc1)cc2)C3NCCC(O)C3 | InChi: | InChI=1S/C22H24N4O2/c23-13-16-3-7-18(8-4-16)17-5-1-15(2-6-17)11-19(14-24)26-22(28)21-12-20(27)9-10-25-21/h1-8,14,19-21,24-25,27H,9-12H2,(H,26,28)/b24-14+/t19-,20-,21-/m0/s1 | Definition date: | 2013-10-31 | Last modified: | 2024-09-27 | Release date: | 2014-03-19 | Identifier: | (2S,4S)-N-[(2S,3E)-1-(4'-cyanobiphenyl-4-yl)-3-iminopropan-2-yl]-4-hydroxypiperidine-2-carboxamide |
|
| ZUV | Name: | ethyl (R)-(10-{[(but-3-yn-1-yl)carbamoyl]oxy}decyl)phosphonofluoridate | Formula: | C17 H31 F N O4 P | SMILES: | FP(=O)(CCCCCCCCCCOC(=O)NCCC#C)OCC | InChi: | InChI=1S/C17H31FNO4P/c1-3-5-14-19-17(20)22-15-12-10-8-6-7-9-11-13-16-24(18,21)23-4-2/h1H,4-16H2,2H3,(H,19,20)/t24-/m1/s1 | Definition date: | 2023-04-04 | Last modified: | 2024-09-27 | Release date: | 2024-04-17 | Identifier: | ethyl (R)-(10-{[(but-3-yn-1-yl)carbamoyl]oxy}decyl)phosphonofluoridate |
|
| SDK | Name: | 1,3-BIS[[N-[(PHENYLMETHOXY)CARBONYL]-L-LEUCYL]AMINO]-2-PROPANONE | Formula: | C31 H42 N4 O7 | SMILES: | O=C(OCc1ccccc1)NC(C(=O)NCC(=O)CNC(=O)C(NC(=O)OCc2ccccc2)CC(C)C)CC(C)C | InChi: | InChI=1S/C31H42N4O7/c1-21(2)15-26(34-30(39)41-19-23-11-7-5-8-12-23)28(37)32-17-25(36)18-33-29(38)27(16-22(3)4)35-31(40)42-20-24-13-9-6-10-14-24/h5-14,21-22,26-27H,15-20H2,1-4H3,(H,32,37)(H,33,38)(H,34,39)(H,35,40)/t26-,27-/m0/s1 | Synonyms: | SYMMETRIC DIACYLAMINOETHYL KETONE | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | benzyl [(1S,9S)-1,9-bis(2-methylpropyl)-2,5,8,11-tetraoxo-13-phenyl-12-oxa-3,7,10-triazatridec-1-yl]carbamate (non-preferred name) |
|
| V7S | Name: | 1,3-bis[(methylsulfanyl)methyl]benzene | Formula: | C10 H14 S2 | SMILES: | CSCc1cccc(c1)CSC | InChi: | InChI=1S/C10H14S2/c1-11-7-9-4-3-5-10(6-9)8-12-2/h3-6H,7-8H2,1-2H3 | Definition date: | 2020-07-13 | Last modified: | 2024-09-27 | Release date: | 2020-11-18 | Identifier: | 1,3-bis[(methylsulfanyl)methyl]benzene |
|
| T6W | Name: | 2-[2-chloranyl-4-[oxidanyl(oxidanylidene)-$l^{4}-azanyl]phenoxy]-2-methyl-~{N}-(2-sulfanylethyl)propanamide | Formula: | C12 H16 Cl N2 O4 S | SMILES: | CC(C)(Oc1ccc(cc1Cl)[N+](O)=O)C(=O)NCCS | InChi: | InChI=1S/C12H15ClN2O4S/c1-12(2,11(16)14-5-6-20)19-10-4-3-8(15(17)18)7-9(10)13/h3-4,7H,5-6H2,1-2H3,(H2-,14,16,17,18,20)/p+1 | Definition date: | 2020-12-15 | Last modified: | 2024-09-27 | Release date: | 2021-07-07 | Identifier: | [3-chloranyl-4-[2-methyl-1-oxidanylidene-1-(2-sulfanylethylamino)propan-2-yl]oxy-phenyl]-oxidanyl-oxidanylidene-azanium |
|
| WIO | Name: | (1R,2S)-2-[(N-{[2-(3-fluorophenoxy)-2-methylpropoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | Formula: | C24 H36 F N3 O9 S | SMILES: | CC(C)CC(NC(=O)OCC(C)(C)Oc1cccc(F)c1)C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)O | InChi: | InChI=1S/C24H36FN3O9S/c1-14(2)10-18(28-23(32)36-13-24(3,4)37-17-7-5-6-16(25)12-17)21(30)27-19(22(31)38(33,34)35)11-15-8-9-26-20(15)29/h5-7,12,14-15,18-19,22,31H,8-11,13H2,1-4H3,(H,26,29)(H,27,30)(H,28,32)(H,33,34,35)/t15-,18-,19-,22+/m0/s1 | Definition date: | 2022-09-13 | Last modified: | 2024-09-27 | Release date: | 2022-09-21 | Identifier: | (1R,2S)-2-[(N-{[2-(3-fluorophenoxy)-2-methylpropoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
| TLQ | Name: | 4-(2-phenylimidazol-1-yl)naphthalene-1-carbaldehyde | Formula: | C20 H14 N2 O | SMILES: | O=Cc1ccc(n2ccnc2c3ccccc3)c4ccccc14 | InChi: | InChI=1S/C20H14N2O/c23-14-16-10-11-19(18-9-5-4-8-17(16)18)22-13-12-21-20(22)15-6-2-1-3-7-15/h1-14H | Definition date: | 2021-01-11 | Last modified: | 2024-09-27 | Release date: | 2021-06-16 | Identifier: | 4-(2-phenylimidazol-1-yl)naphthalene-1-carbaldehyde |
|
| XUJ | Name: | (2R)-2-amino-4-boronobutanoic acid | Formula: | C4 H10 B N O4 | SMILES: | B(O)(CCC(C(O)=O)N)O | InChi: | InChI=1S/C4H10BNO4/c6-3(4(7)8)1-2-5(9)10/h3,9-10H,1-2,6H2,(H,7,8)/t3-/m1/s1 | Definition date: | 2021-01-13 | Last modified: | 2024-09-27 | Release date: | 2022-02-23 | Identifier: | (2R)-2-amino-4-boronobutanoic acid |
|
| V7T | Name: | (2R)-6-azanyl-2-carbamimidamido-hexanoic acid | Formula: | C7 H16 N4 O2 | SMILES: | NCCCC[CH](NC(N)=N)C(O)=O | InChi: | InChI=1S/C7H16N4O2/c8-4-2-1-3-5(6(12)13)11-7(9)10/h5H,1-4,8H2,(H,12,13)(H4,9,10,11)/t5-/m1/s1 | Definition date: | 2021-04-23 | Last modified: | 2024-09-27 | Release date: | 2022-04-06 | Identifier: | (2~{R})-6-azanyl-2-carbamimidamido-hexanoic acid |
|
| URR | Name: | N~2~-(ethoxycarbonyl)-N-{(1S,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-1-sulfanylpropan-2-yl}-L-leucinamide | Formula: | C24 H37 N3 O9 S2 | SMILES: | CC(C)CC(NC(=O)OCC(C)(C)S(=O)c1ccccc1)C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)O | InChi: | InChI=1S/C24H37N3O9S2/c1-15(2)12-18(27-23(31)36-14-24(3,4)37(32)17-8-6-5-7-9-17)21(29)26-19(22(30)38(33,34)35)13-16-10-11-25-20(16)28/h5-9,15-16,18-19,22,30H,10-14H2,1-4H3,(H,25,28)(H,26,29)(H,27,31)(H,33,34,35)/t16-,18-,19-,22-,37?/m0/s1 | Definition date: | 2022-08-23 | Last modified: | 2024-09-27 | Release date: | 2022-09-07 | Identifier: | (1S,2S)-2-[(N-{[2-(benzenesulfinyl)-2-methylpropoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|